Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Accounts Payables (2019 - 2025)

Historic Accounts Payables for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $230768.0.

  • Bioadaptives' Accounts Payables fell 5126.35% to $230768.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $230768.0, marking a year-over-year decrease of 5126.35%. This contributed to the annual value of $179458.0 for FY2024, which is 5954.32% down from last year.
  • Latest data reveals that Bioadaptives reported Accounts Payables of $230768.0 as of Q3 2025, which was down 5126.35% from $204081.0 recorded in Q2 2025.
  • Over the past 5 years, Bioadaptives' Accounts Payables peaked at $473501.0 during Q3 2024, and registered a low of $57258.0 during Q1 2021.
  • In the last 5 years, Bioadaptives' Accounts Payables had a median value of $391399.0 in 2022 and averaged $316179.9.
  • In the last 5 years, Bioadaptives' Accounts Payables soared by 46746.83% in 2022 and then plummeted by 5954.32% in 2024.
  • Bioadaptives' Accounts Payables (Quarter) stood at $247750.0 in 2021, then soared by 65.46% to $409920.0 in 2022, then rose by 8.21% to $443579.0 in 2023, then plummeted by 59.54% to $179458.0 in 2024, then rose by 28.59% to $230768.0 in 2025.
  • Its Accounts Payables stands at $230768.0 for Q3 2025, versus $204081.0 for Q2 2025 and $196816.0 for Q1 2025.